The pursuit of ex vivo erythrocyte generation has led to the development of various culture systems that simulate the bone marrow microenvironment. However, these models often fail to fully replicate the hematopoietic niche's complex dynamics. In our research, we use a comprehensive strategy that emphasizes physiological red blood cell (RBC) differentiation using a minimal cytokine regimen. A key innovation in our approach is the integration of a 3-dimensional (3D) silk-based scaffold engineered to mimic both the physical and chemical properties of human bone marrow. This scaffold facilitates critical macrophage-RBC interactions and incorporates fibronectin functionalization to support the formation of erythroblastic island (EBI)-like niches. We observed diverse stages of erythroblast maturation within these niches, driven by the activation of autophagy, which promotes organelle clearance and membrane remodeling. This process leads to reduced surface integrin expression and significantly enhances RBC enucleation. Using a specialized bioreactor chamber, millions of RBCs can be detached from the EBIs and collected in transfusion bags via dynamic perfusion. Inhibition of autophagy through pharmacological agents or alpha 4 integrin blockade disrupted EBI formation, preventing cells from completing their final morphological transformations, having them trapped in the erythroblast stage. Our findings underscore the importance of the bone marrow niche in maintaining the structural integrity of EBIs and highlight the critical role of autophagy in facilitating organelle clearance during RBC maturation. RNA sequencing analysis further confirmed that these processes are uniquely supported by the 3D silk scaffold, which is essential for enhancing RBC production ex vivo.

In vitro studies of human erythropoiesis using a 3D silk-based bone marrow model that generates erythroblastic islands / C. A Di Buduo, F. Careddu, S. Metti, M. Lunghi, S. Diprima, V. Camilotto, G. Bruni, U. Gianelli, D. Tosi, C. Perotti, C. Del Fante, M. Cazzola, P. Braghetta, D. L Kaplan, G. Minetti, L. Malcovati, A. Balduini. - In: BLOOD ADVANCES. - ISSN 2473-9529. - 9:9(2025 May 13), pp. 1-15.

In vitro studies of human erythropoiesis using a 3D silk-based bone marrow model that generates erythroblastic islands

G. Bruni;U. Gianelli;D. Tosi;
2025

Abstract

The pursuit of ex vivo erythrocyte generation has led to the development of various culture systems that simulate the bone marrow microenvironment. However, these models often fail to fully replicate the hematopoietic niche's complex dynamics. In our research, we use a comprehensive strategy that emphasizes physiological red blood cell (RBC) differentiation using a minimal cytokine regimen. A key innovation in our approach is the integration of a 3-dimensional (3D) silk-based scaffold engineered to mimic both the physical and chemical properties of human bone marrow. This scaffold facilitates critical macrophage-RBC interactions and incorporates fibronectin functionalization to support the formation of erythroblastic island (EBI)-like niches. We observed diverse stages of erythroblast maturation within these niches, driven by the activation of autophagy, which promotes organelle clearance and membrane remodeling. This process leads to reduced surface integrin expression and significantly enhances RBC enucleation. Using a specialized bioreactor chamber, millions of RBCs can be detached from the EBIs and collected in transfusion bags via dynamic perfusion. Inhibition of autophagy through pharmacological agents or alpha 4 integrin blockade disrupted EBI formation, preventing cells from completing their final morphological transformations, having them trapped in the erythroblast stage. Our findings underscore the importance of the bone marrow niche in maintaining the structural integrity of EBIs and highlight the critical role of autophagy in facilitating organelle clearance during RBC maturation. RNA sequencing analysis further confirmed that these processes are uniquely supported by the 3D silk scaffold, which is essential for enhancing RBC production ex vivo.
Settore BIOS-09/A - Biochimica clinica e biologia molecolare clinica
Settore MEDS-04/A - Anatomia patologica
Settore AGRI-06/B - Chimica agraria
   Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based scaffold bioreactor
   SilkPlatelet
   European Commission
   Horizon Europe Framework Programme
   101058349

   Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicine
   SILKink
   European Commission
   Horizon Europe Framework Programme
   101113073
13-mag-2025
29-apr-2025
Article (author)
File in questo prodotto:
File Dimensione Formato  
blooda_adv-2024-014905-main1.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 11.23 MB
Formato Adobe PDF
11.23 MB Adobe PDF Visualizza/Apri
blooda_adv-2024-014905-main1_compressed.pdf

accesso aperto

Descrizione: Compressed
Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 2.23 MB
Formato Adobe PDF
2.23 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1184437
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
  • OpenAlex 4
social impact